CIK 0001644963 · Non-accelerated filer<br>Smaller reporting company
AVENUE THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATXI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474113275
- Phone
- 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-17 | Vazzano Joseph Walter Chief Financial Officer | Grant or award | +100,505 | 165,757 | ||
| 2021-09-15 | Vazzano Joseph Walter Chief Financial Officer | Sale | −7,160 | $1.62 | $12K | 65,252 |
| 2021-05-06 | Herskowitz Neil Director | Purchase | +2,500 | $3.99 | $10K | 134,724 |
| 2020-08-20 | Vazzano Joseph Walter Chief Financial Officer | Sale | −3,840 | $12.13 | $47K | 57,412 |
| 2020-06-16 | KRANZLER JAY D Director | Grant or award | +10,000 | 84,663 | ||
| 2020-06-16 | Herskowitz Neil Director | Grant or award | +10,000 | 132,224 | ||
| 2020-03-10 | Vazzano Joseph Walter Chief Financial Officer | Purchase | +1,889 | $7.94 | $15K | 61,252 |
| 2020-03-09 | Vazzano Joseph Walter Chief Financial Officer | Purchase | +1,400 | $7.99 | $11K | 59,263 |
| 2020-03-09 | Vazzano Joseph Walter Chief Financial Officer | Purchase | +100 | $7.97 | $797 | 59,363 |
| 2020-02-27 | Herskowitz Neil Director | Purchase | +2,400 | $8.20 | $20K | 122,224 |
| 2020-02-26 | Herskowitz Neil Director | Purchase | +161 | $8.73 | $1K | 119,824 |
| 2020-02-25 | Vazzano Joseph Walter Chief Financial Officer | Purchase | +1,200 | $9.09 | $11K | 57,863 |
| 2020-02-25 | Herskowitz Neil Director | Purchase | +10,000 | $9.31 | $93K | 119,663 |
| 2020-02-12 | Vazzano Joseph Walter Chief Financial Officer | Grant or award · Restricted Stock Units | +22,727 | 50,505 | ||
| 2020-02-12 | Lu Lucy President, CEO | Grant or award · Restricted Stock Units | +110,959 | 246,576 | ||
| 2019-09-12 | Ingram Elizabeth Garrett Director | Purchase | +16,000 | $6.27 | $100K | 16,000 |
| 2019-08-27 | KRANZLER JAY D Director | Grant or award | +10,000 | 74,663 | ||
| 2019-08-27 | Herskowitz Neil Director | Grant or award | +10,000 | 109,663 | ||
| 2019-08-09 | Vazzano Joseph Walter Chief Financial Officer | Sale | −2,375 | $5.56 | $13K | 56,663 |
| 2019-08-08 | Vazzano Joseph Walter Chief Financial Officer | Sale | −2,313 | $5.62 | $13K | 59,038 |
Page 3 of 6 · 101 trades